Review Article
Year: 2020 | Month: September | Volume: 7 | Issue: 9 | Pages: 413-419
A Brief Overview on Plasma Therapy on Novel Corona Virus
Yogesh Ratanpara, Rajashree Mashru
Faculty of Pharmacy, Kalabhavan, the Maharaja Sayajirao University of Baroda, Vadodara - 390001, Gujarat
Corresponding Author: Rajashree Mashru
ABSTRACT
The corona virus disease (COVID-19) was first identified in Wuhan, China in December 2019. Corona virus is a group of related virus which is responsible for producing disease in mammals and birds. Corona virus is responsible for producing COVID-19 disease which produces respiratory illness in human. The objective of this article is that to identify the history of the corona virus, classification of corona virus, structure of corona virus, SARS CoV-2 control, prevention and possible treatment of corona virus disease (COVID-19) using plasma therapy. The world health organization (WHO) declared 'pandemic' situation because of the spreading of corona virus disease (COVID-19). As of December 2019, this epidemic had spread to 213 countries with 85 lakh confirmed cases, including 4.5 lakh deaths at 18 June 2020. There are various drugs and treatments are used to treat COVID-19 such as convalescent plasma therapy. The convalescent plasma therapy is method to transfer plasma of patients which is recovered from virus infection to the corona infected patients. The convalescent plasma contains antibodies against corona virus. The convalescent plasma therapy is not fully effective treatment for COVID-19 disease. The convalescent plasma therapy has great potential to treat COVID-19 disease in early stages but large scale in-vivo study is required to get a significant data to prove the efficacy of the treatment.
Keywords: COVID-19, SARS CoV-2, convalescent plasma, neutralizing antibodies,
[PDF Full Text]